- Book
- September 2022
- 400 Pages
- Book
- April 2022
- 480 Pages
- Book
- February 2022
- 544 Pages
- Book
- December 2021
- 528 Pages
- Book
- December 2021
- 624 Pages
- Book
- September 2021
- 576 Pages
- Book
- September 2021
- 464 Pages
- Book
- June 2021
- 640 Pages
- Book
- April 2021
- 6032 Pages
€4064EUR$4,607USD£3,333GBP
- Book
- March 2021
- 320 Pages
- Book
- February 2021
- 432 Pages
- Book
- January 2021
- 320 Pages
- Book
- April 2020
- 608 Pages
- Book
- December 2019
- 400 Pages
- Book
- October 2019
- 472 Pages
- Book
- September 2019
- 272 Pages
- Book
- September 2019
- 392 Pages
- Book
- June 2019
- 496 Pages
- Book
- February 2019
- 512 Pages
- Book
- September 2018
- 576 Pages

The Drug Development market within the context of Biotechnology is a highly competitive and complex industry. It involves the research, development, and commercialization of new drugs and treatments for a variety of diseases and conditions. This process requires a significant amount of resources, including capital, personnel, and technology. The development of a new drug or treatment typically involves a long and expensive process of clinical trials and regulatory approval.
The Drug Development market is a major component of the biotechnology industry, and is a key driver of innovation and economic growth. It is also a major source of employment, with many companies employing thousands of people in research and development, manufacturing, and marketing.
Some of the major companies in the Drug Development market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Johnson & Johnson. Other notable companies include AstraZeneca, Sanofi, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more